Buy now (catalyst-driven): Price is consolidating near the pivot (~64.63) with improving downside momentum (MACD negative but contracting) and supportive positioning (hedge funds aggressively adding; put/call OI < 1).
Primary thesis: The ongoing strategic alternatives review keeps a transaction/takeout narrative alive, which can override “meh” fundamentals short-term.
Near-term roadmap: A clean push above 65.72 (R1) improves odds of a move toward 66.39 (R2); downside levels to watch are 63.55 (S1) then 62.88 (S2).
Pattern-based forward view: Similar-pattern stats imply +12.14% over the next month (but slightly negative next day/week).
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning (OI): Put/Call open interest ratio 0.79 (calls > puts) = mildly bullish sentiment.
Liquidity/participation: 0 contracts traded today (very thin), so options sentiment is more about positioning than active conviction.
Volatility: 30D IV 37.78 vs historical vol 15.5 = options are pricing elevated uncertainty (consistent with strategic-alternatives/transaction optionality).
IV context: IV percentile 54.6 (mid-range), IV rank 10.75 (low-ish versus its own range), suggesting IV isn’t at extreme highs despite being well above realized vol.
Technical Summary
Sell
5
Buy
5
Positive Catalysts
Strategic alternatives review: Supports a potential takeout/asset sale re-rating; multiple analysts explicitly flag the portfolio as attractive to buyers.
Hedge fund flow: Hedge funds are buying, with reported buying amount up +1474.48% QoQ.
Upcoming earnings: QDEC 2025 earnings on 2026-02-23 (after hours) can reset the narrative if guidance/NOI trends improve.
Rates sensitivity (REIT tailwind): Any easing in rate expectations typically helps multifamily REIT valuations (even without company-specific news).
Neutral/Negative Catalysts
Fundamentals headline weakness: Latest reported quarter shows a sharp YoY drop in net income and EPS (see financials) which can cap multiple expansion without clear normalization.
Analyst stance mostly neutral: Recent actions cluster around Neutral/Market Perform/Equal Weight, implying limited near-term conviction absent a deal.
Sector backdrop: Commentary flags softer apartment rent momentum tied to a tepid job market, reducing organic growth visibility.
Options market is illiquid today: Zero volume reduces usefulness of real-time options sentiment.
Profitability: Net income $53.783M, -972.25% YoY and EPS 2.72, -780% YoY (major YoY compression; suggests the prior period likely benefited from non-recurring items and/or current period has unusual impacts—either way, headline earnings trend is weak).
Margins: Gross margin 17.3%, +2.85% YoY (some operating improvement, but not translating into stable bottom-line YoY).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: Ratings have moved toward neutral as the stock rallied and the strategic review introduced outcome uncertainty.
Key changes:
Raymond James (2025-11-12): Double downgrade to Market Perform from Strong Buy (no PT), citing valuation gap closure and uncertain strategic outcomes.
UBS (2025-11-10): Neutral, PT raised to $63.
Piper Sandler (2025-11-10): Neutral, PT trimmed to $66.
Wells Fargo (2025-11-17): Equal Weight, PT raised to $74 (probability-weighted transaction framework), but still sidelines due to relative total return vs preferred REITs.
Wall Street pros: Transaction optionality; portfolio attractiveness to buyers; some PTs lifted on deal probability.
Wall Street cons: Limited confidence in standalone cash-flow growth and sector rent momentum; valuation no longer “cheap enough” to justify bullish ratings without a deal.
Wall Street analysts forecast CSR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CSR is 69.28 USD with a low forecast of 64.5 USD and a high forecast of 79 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
Wall Street analysts forecast CSR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CSR is 69.28 USD with a low forecast of 64.5 USD and a high forecast of 79 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
6 Hold
0 Sell
Moderate Buy
Current: 64.270
Low
64.5
Averages
69.28
High
79
Current: 64.270
Low
64.5
Averages
69.28
High
79
Wells Fargo
Cooper Clark
Equal Weight
maintain
$60 -> $74
AI Analysis
2025-11-17
Reason
Wells Fargo
Cooper Clark
Price Target
$60 -> $74
AI Analysis
2025-11-17
maintain
Equal Weight
Reason
Wells Fargo analyst Cooper Clark raised the firm's price target on Centerspace to $74 from $60 and keeps an Equal Weight rating on the shares. The firm now applies a blended NAV and AFFO Multiple price target to reflect a probability weighting for a transaction. Wells' estimated total return still lags its Overweight-rated REITs, which keeps the firm on the sidelines on Centerspace.
Raymond James
Buck Horne
Strong Buy -> Market Perform
downgrade
2025-11-12
Reason
Raymond James
Buck Horne
Price Target
2025-11-12
downgrade
Strong Buy -> Market Perform
Reason
Raymond James analyst Buck Horne double downgraded Centerspace to Market Perform from Strong Buy without a price target. The company's board has formally engaged financial and legal advisors to perform a strategic alternatives review, the analyst tells investors in a research note. The firm believes Centerspace's portfolio is an attractive target for any number of potential buyers. However, with the shares closing the valuation gap versus its multifamily peers "amid a backdrop of uncertain outcomes," it feels stepping back to a neutral rating is appropriate on the recent rally.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CSR